CHEMOMAB THERAPEUTICS LTD SPON ADS EACH REP 20 ORD SHS
(NASDAQ: CMMB)

Chemomab Therapeutics Ltd. operates as a clinical-stage biotech company. It discovers and develops therapeutics for conditions with unmet need that involve Inflammation and fibrosis. The company was founded by Adi Mor on September 22, 2011 and is headquartered in Tel Aviv, Israel.

0.629

+0.039 (+6.61%)
Range 0.620 - 0.700   (12.90%)
Open -
Previous Close 0.590
Bid Price 1.690
Bid Volume 40
Ask Price 1.700
Ask Volume 18
Volume 29,723
Value -
Remark
Delayed prices. Updated at 18 Apr 2024 22:29.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis